Clinical Trial Update: Pulse Corticosteroids Or/and Immunoglobulins to Treat Fulminant Myocarditis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating pulse corticosteroids and intravenous immunoglobulin to treat fulminant myocarditis, sponsored by Assistance Publique - Hôpi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fulminant Myocarditis
• Myocarditis

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)
• Methylprednisolone (pulse therapy) (methylprednisolone)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Myocarditis Acute | Phase 2 | Status: NOT_YET_RECRUITING